RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q2 2020 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC)
Q2 2020 Earnings Conference Call
August 06, 2020 04:30 PM ET
Company Participants
Jeanie Herbert - Head, Investor Relations & Corporate Communications
Mark Foley - President & Chief Executive Officer
Dustin Sjuts - Chief Commercial Officer, Aesthetics & Therapeutics
Toby Schilke - Chief Financial Officer
Abhay Joshi - Chief Operating Officer & President of R&D & Product Operations
Conference Call Participants
Terence Flynn - Goldman Sachs
Stacy Ku - Cowen & Company
David Amsellem - Piper Sandler
Balaji Prasad - Barclays
Tim Lugo - William Blair
Tian Sun - Needham &